Bolamperti Simona, Villa Isabella, Rubinacci Alessandro
Osteoporosis and Bone and Mineral Metabolism Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milano, Italy.
Bone Res. 2022 Jul 18;10(1):48. doi: 10.1038/s41413-022-00219-8.
Bone remodeling replaces old and damaged bone with new bone through a sequence of cellular events occurring on the same surface without any change in bone shape. It was initially thought that the basic multicellular unit (BMU) responsible for bone remodeling consists of osteoclasts and osteoblasts functioning through a hierarchical sequence of events organized into distinct stages. However, recent discoveries have indicated that all bone cells participate in BMU formation by interacting both simultaneously and at different differentiation stages with their progenitors, other cells, and bone matrix constituents. Therefore, bone remodeling is currently considered a physiological outcome of continuous cellular operational processes optimized to confer a survival advantage. Bone remodeling defines the primary activities that BMUs need to perform to renew successfully bone structural units. Hence, this review summarizes the current understanding of bone remodeling and future research directions with the aim of providing a clinically relevant biological background with which to identify targets for therapeutic strategies in osteoporosis.
骨重塑通过在同一骨表面发生的一系列细胞活动,用新骨替代旧骨和受损骨,且骨形状不变。最初人们认为,负责骨重塑的基本多细胞单位(BMU)由破骨细胞和成骨细胞组成,它们通过组织成不同阶段的分级事件序列发挥作用。然而,最近的发现表明,所有骨细胞通过与其祖细胞、其他细胞以及骨基质成分同时且在不同分化阶段相互作用,参与BMU的形成。因此,目前认为骨重塑是为赋予生存优势而优化的连续细胞操作过程的生理结果。骨重塑定义了BMU为成功更新骨结构单位而需要执行的主要活动。因此,本综述总结了目前对骨重塑的理解以及未来的研究方向,旨在提供一个与临床相关的生物学背景,以便确定骨质疏松症治疗策略的靶点。